Big Developments In Cancer Research - KAUZ-TV: Newschannel 6 Now | Wichita Falls, TX

Big Developments In Cancer Research

Dr. Praveen Reddy with Texas Oncology, came on Newschannel 6 at Noon to share some of the big announcements from this year's American Society of Clinical Oncology meeting:

PROSTATE CANCER:

  • Men with advanced prostate cancer are benefiting from a new medication called Zytiga. Through clinical trials, it was discovered that a third of men with advanced prostate cancer who received the drug coupled with hormone therapy prior to surgery had only a little or no cancer at all after six months of treatment. This is very significant since most men with advanced prostate cancer have a poor prognosis due to the cancer metastasizing.
  • Click here for more information.

 

  • Additionally, it was discovered that men with minimally-spread hormone-sensitive prostate cancer benefit from continuous hormone therapy rather than intermittent hormone therapy, which was the typical treatment for prostate cancer because it was believed that it would help reduce side effects such as loss of sexual desire, weight gain, impotence, and hot flashes. However, the new study shows that men who received continuous hormone lived about two years longer than those who received intermittent hormone therapy.
  • Click here for more information.

LUNG CANCER:

  • Another big breakthrough presented at ASCO this year was the targeted therapy drug afatinib. A study showed that the drug was better than chemotherapy at keeping advanced non-small cell lung cancer (NSCLC) with mutations (changes) to the epidermal growth factor receptor (EGFR) from progressing longer.  The research showed that it took about four months longer for the cancer to progress when patients received afatinib. The drug also helped slow the development of symptoms associated with lung cancer, such as coughing and shortness of breath. Additionally, since the drug is taken orally, there are less office visits than if they were receiving chemotherapy.
  • Click here for more information.

BREAST CANCER:

  • A new breast cancer treatment dubbed the ‘smart bomb' improves the time that women with very advanced breast cancer live without the disease progressing. The treatment delivers a toxic load of chemotherapy to cancerous cells by binding it with Herceptin, the first gene-targeted therapy for breast cancer. The treatment is referred to as T-DM1 and causes fewer side effects. Women who underwent this treatment didn't experience hair loss or nausea, and the surrounding healthy tissue was left unaffected.  
  • Click here for more information.  

THE FUTURE FOR CANCER TREATMENT:  

  • Cancer treatment is getting more targeted, and we are able to test and target specific genetic mutations and attack cancerous cells without sacrificing the health of healthy tissue and cells. This will result in more effective treatment and lessen the side effects of cancer treatment overall.

 

  • News HeadlinesNewsMore>>

  • Even with Trump warning, Mueller likely to probe finances

    Even with Trump warning, Mueller likely to probe finances

    Thursday, July 20 2017 5:08 AM EDT2017-07-20 09:08:03 GMT
    Friday, July 21 2017 2:00 AM EDT2017-07-21 06:00:07 GMT

    Donald Trump Jr. is scheduled to appear July 26 before the Senate Judiciary Committee along with former campaign chairman Paul Manafort, according to a witness list released by the panel Wednesday.

    Donald Trump Jr. is scheduled to appear July 26 before the Senate Judiciary Committee along with former campaign chairman Paul Manafort, according to a witness list released by the panel Wednesday.

  • Facebook working on way to charge for reading news articles

    Facebook working on way to charge for reading news articles

    Wednesday, July 19 2017 3:08 PM EDT2017-07-19 19:08:10 GMT
    Friday, July 21 2017 1:13 AM EDT2017-07-21 05:13:00 GMT

    Facebook is launching a news subscription product to help publishers make money from the articles people share and read on its platform.

    Facebook is launching a news subscription product to help publishers make money from the articles people share and read on its platform.

  • Rider High School senior receives perfect score on ACT

    Rider High School senior receives perfect score on ACT

    Friday, July 21 2017 12:13 AM EDT2017-07-21 04:13:09 GMT
    Caleigh Studer of Rider High School earned a perfect score of 36 on the ACT test she took in June.Caleigh Studer of Rider High School earned a perfect score of 36 on the ACT test she took in June.

    Caleigh Studer of Rider High School earned a perfect score of 36 on the ACT test she took in June.

    Caleigh Studer of Rider High School earned a perfect score of 36 on the ACT test she took in June.

Powered by Frankly